Construction of expression vectors using initiation sites of DNA replication and their application to gene therapy

利用DNA复制起始位点构建表达载体及其在基因治疗中的应用

基本信息

  • 批准号:
    04557105
  • 负责人:
  • 金额:
    $ 9.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

We have determined the initiation regions in the various genes including human c-myc, N-myc, p53, hsp70, and mouse immunoglobulin heavy chain gene (IgH). The plasmid clones containing the these origin regions were also functioning as the ARSs in transfected mammalian cultured cells and transgenic mouse cells. These systems should be useful for the expression vector to produce the bio-active reagents in a large amounts. Furthermore, we have identified the protein factors that regulate the replication levels of the introduced plasmid DNAs. The combination between the DNA element essential for the initiation of DNA replication and protein factors regulating the replication enhances the production of the materials of interest. Details we have clarified are following.HindIII-PstI region positioned upstream of c-myc gene was identified as origin and transcriptional enhancer. Clone containing this region replicated in cltured cells and transgenic mice in an episomal state. The 21 nucleotide w … More as identified to be essential for replication. The protein complex containing c-myc protein was then identified to act the regulation of this plasmid DNA.One of the protein involved in this c-myc protein complex was identified as MSSP, and two cDNAs were cloned, MSSP-1 and MSSP-2. These proteins bound to both double and single stranded DNA in a sequence-specific manner, and promoted the initiation of replication. One of the plasmid recovered from transgenic mice bearing this c-myc-origin possessed the extra sequence beside the c-myc origin. This sequence, TRM, enhanced the efficiency of replication to approximately 100 fold to that without TRM.Binding proteins recognizing TRM were next identified.We further identified the origins in the various genes described above. Essential sequences and recognition proteins to function were next determined as in the case of c-myc gene. Detail experiments were carried out, and we got the similar relationship between cis and trans elements.The experimental results described here show the promising strategy for application to the gene therapy. Less
我们已经确定了各种基因中的主动区域,包括人C-Myc,N-MYC,p53,HSP70和小鼠免疫球蛋白重链基因(IGH)。包含这些原点区域的质粒克隆在翻译的哺乳动物培养细胞和转基因小鼠细胞中也起作用。这些系统对于表达载体应大量产生生物活性试剂有用。此外,我们已经确定了调节引入质粒DNA的复制水平的蛋白质因子。 DNA元件对启动DNA复制至关重要的组合之间的组合与重复复制的蛋白质因子之间的结合增强了感兴趣材料的产生。我们已经阐明的细节正在遵循。将C-MYC基因上游定位的Hindiiii-PSTI区域鉴定为原点和转录增强子。含有该区域的克隆在偶发状态下复制的细胞和转基因小鼠。 21核苷酸W…更多地确定为复制至关重要。然后确定含有C-MYC蛋白的蛋白质复合物以作用于该质粒DNA的调节。将参与该C-MYC蛋白复合物涉及的蛋白质的一种被鉴定为MSSP,并克隆了两个CDNA,MSSP-1和MSSP-2。这些蛋白质以序列特异性方式与双重和单链DNA结合,并促进了复制的主动性。从带有这种C-Myc-基的转基因小鼠中回收的质粒之一,在C-Myc起源旁边具有额外的序列。接下来鉴定了该序列TRM,将复制的效率提高到大约100倍的情况下,而没有Trm。结合蛋白质识别TRM。我们进一步鉴定了上述各种基因中的起源。接下来确定了起作用的基本序列和识别蛋白,如C-MYC基因而言。进行了详细的实验,我们得到了顺式和反式元素之间的相似关系。此处描述的实验结果显示了适用于基因治疗的有望策略。较少的

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Imamura,Y.: "The upstream region of the mouse N-myc gene:identification of an enhancer element that functions preferentially in neuroblastoma..." Biochim.Biophys.Acta. 1132. 177-187 (1992)
Imamura,Y.:“小鼠 N-myc 基因的上游区域:鉴定在神经母细胞瘤中优先发挥作用的增强子元件......”Biochim.Biophys.Acta。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ariga, H., Taira, T.and Iguchi-Ariga, S.M.M.: "Identification of DNA replication origin and characterization of functional proteins in human hsp70 gene." J.UOEH. 15. 294 (1993)
Ariga, H.、Taira, T. 和 Iguchi-Ariga, S.M.M.:“人类 hsp70 基因中 DNA 复制起点的鉴定和功能蛋白的表征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Negishi, Y., Nishita, Y., Saegusa, Y., Galli, I., Miyajima, N., Tamai, H., Kihara, F., Iguchi-Ariga, S.M.M., and Ariga. H.: "Identification and cDNA cloning of single-stranded DNA binding proteins that interact with the region upstream of the human c-myc
Negishi, Y.、Nishita, Y.、Saegusa, Y.、Galli, I.、Miyajima, N.、Tamai, H.、Kihara, F.、Iguchi-Ariga、S.M.M. 和 Ariga。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iguchi-Ariga,S.M.M.: "Identification of initiation region of DNA replication in murine immunoglobulin heavy chain gene and possible function of octamer motif as a putatibe DNA replication origin in mammalian cells." Biochim.Biophys.Acta. 1172. 73-81 (1993
Iguchi-Ariga,S.M.M.:“鼠免疫球蛋白重链基因中 DNA 复制起始区的鉴定以及八聚体基序作为哺乳动物细胞中假定的 DNA 复制起点的可能功能。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iguchi-Ariga, S.M.M., Ogawa N., and Ariga, H.: "Identification of initiation region of DNA replication in murine immunoglobulin heavy chain gene and possible function of octamer motif as a putatibe DNA replication origin in mammalian cells." Biochim.Biphy
Iguchi-Ariga, S.M.M.、Okawa N. 和 Ariga, H.:“鉴定小鼠免疫球蛋白重链基因中 DNA 复制的起始区域以及八聚体基序作为哺乳动物细胞中假定的 DNA 复制起点的可能功能。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARIGA Hiroyoshi其他文献

ARIGA Hiroyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARIGA Hiroyoshi', 18)}}的其他基金

Functional analysis of DJ-1, a causative gene for familial Parkinson's disease, and its pharmaceutical application
家族性帕金森病致病基因DJ-1的功能分析及其药物应用
  • 批准号:
    21390014
  • 财政年份:
    2009
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Function of DJ-1, a causative gene for familial Parkinson's disease PARK7 and oncogene
家族性帕金森病致病基因 PARK7 和癌基因 DJ-1 的功能
  • 批准号:
    18390018
  • 财政年份:
    2006
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functions of Myc and c-Myc-binding proteins
Myc 和 c-Myc 结合蛋白的功能
  • 批准号:
    14370736
  • 财政年份:
    2002
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of cell-cycle movement and cell transformation by c-Myc and its binding proteins
c-Myc 及其结合蛋白对细胞周期运动和细胞转化的调节
  • 批准号:
    12470490
  • 财政年份:
    2000
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of cell-cycle movement and cell transformation by nuclear oncogenes.
核癌基因对细胞周期运动和细胞转化的调节。
  • 批准号:
    10470477
  • 财政年份:
    1998
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of cell proliferation and appoptosis by the actions of transcription/replication factors in mammalian cells.
哺乳动物细胞中转录/复制因子作用的细胞增殖和凋亡的分子机制。
  • 批准号:
    08457599
  • 财政年份:
    1996
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of gene therapy vector by using DNA replication origin and virus vector
利用DNA复制起点和病毒载体建立基因治疗载体
  • 批准号:
    07557147
  • 财政年份:
    1995
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Conservative regulation of DNA replication and transcription in mammalian cells
哺乳动物细胞中 DNA 复制和转录的保守调控
  • 批准号:
    06454591
  • 财政年份:
    1994
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Concerted mechanism of DNA replication initiation and transcription in mammalian cells
哺乳动物细胞中 DNA 复制起始和转录的协同机制
  • 批准号:
    03454489
  • 财政年份:
    1991
  • 资助金额:
    $ 9.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

核定位的MCT1结合c-Myc促进细胞周期和卵巢癌进展的机制与功能研究
  • 批准号:
    82303010
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CHD4通过调控骨髓瘤染色质可及性促进相分离激活c-Myc通路的作用机制及干预研究
  • 批准号:
    82373936
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SHMT2介导c-Myc/E2F1调节糖酵解和丙酮酸代谢促进胰腺癌增殖侵袭的机制研究
  • 批准号:
    82360510
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
Dhx9调控Huwe1/c-Myc轴维持造血干细胞稳态的机制研究
  • 批准号:
    82300138
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CircCCDC66调控c-Myc基因m6A甲基化促进胃癌恶性转化的分子机制
  • 批准号:
    82360498
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

The Role of the Fructose-1,6-Bisphoshatase 2 and c-Myc Interaction in Sarcoma Progression
果糖-1,6-双磷酸酶 2 和 c-Myc 相互作用在肉瘤进展中的作用
  • 批准号:
    10536204
  • 财政年份:
    2023
  • 资助金额:
    $ 9.28万
  • 项目类别:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
靶向髓母细胞瘤多种信号通路的脂质纳米药物
  • 批准号:
    10663377
  • 财政年份:
    2022
  • 资助金额:
    $ 9.28万
  • 项目类别:
How does the ubiquitously expressed ZFX mediate cell type-specific transcriptional regulation
普遍表达的 ZFX 如何介导细胞类型特异性转录调控
  • 批准号:
    10458396
  • 财政年份:
    2022
  • 资助金额:
    $ 9.28万
  • 项目类别:
How does the ubiquitously expressed ZFX mediate cell type-specific transcriptional regulation
普遍表达的 ZFX 如何介导细胞类型特异性转录调控
  • 批准号:
    10677572
  • 财政年份:
    2022
  • 资助金额:
    $ 9.28万
  • 项目类别:
Small Molecule N-myc Degraders as Novel Cancer Therapeutic Agents
小分子 N-myc 降解剂作为新型癌症治疗剂
  • 批准号:
    10484078
  • 财政年份:
    2022
  • 资助金额:
    $ 9.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了